Welcome to the international HTA database
Showing [3283 Records] Selected Records [0 Hits] [Clear]
| Year | Source | Title | |
|---|---|---|---|
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Caspofungin acetate | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Esomeprazole magnesium | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Galantamine | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Imatinib mesylate | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Levonorgestrel-releasing intrauterine system | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Nateglinide | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Parecoxib sodium | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Pleconaril | |
| 2001 | Institute for Clinical Evaluative Sciences (ICES) | Health technology assessment of PET (positron emission tomography) | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Rosuvastatin | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Sibutramine | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tacrolimus | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tegaserod | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Telithromycin | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Topical diclofenac sodium | |
| 2001 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Positron emission tomography in Quebec | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Antimicrobial bandages | |
| 2001 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Osteoporosis and fractures among people aged 65 and over: recommendations for an integrated framework for action in Quebec | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Computed tomography laser mammography | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Economic evaluation of zanamivir (relenza) for the treatment of influenza | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Given diagnostic imaging system | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Gliasite radiation therapy | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Cyclosporine for the treatment of aplastic anemia | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | GlucoWatch biographer | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Prevnar(TM): a pneumococcal conjugate vaccine for infants and young children | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Cyclosporine for pure red cell aplasia | |
| 2001 | Health Services Utilization and Research Commission (HSURC) | Planning for Saskatchewan's future: population and health services projections to 2015 | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Prosorba treatment for rheumatoid arthritis | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Selective tubal occlusion procedure | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | TruScan | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Vagus nerve stimulator (VNS) | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Warm-up therapy | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Oseltamivir for the treatment of suspected influenza: a clinical and economic assessment | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | An inventory of seven forms of high-technology radiological equipment in Canada | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | The new fluoroquinolones in community-acquired pneumonia: clinical and economic perspectives | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Novel antipsychotics for patients with attention-deficit hyperactivity disorder: a systematic review | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Transdermally-delivered oxybutynin (Oxytrol(R)) for overactive bladder | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Patient diabetes education in the management of adult type 2 diabetes | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Linezolid for the treatment of serious gram-positive infections | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Assessment of videoconferencing in telehealth in Canada | |
| 2001 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Fragile X syndrome: the role of molecular diagnosis and screening in an integrated approach to services | |
| 2001 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Pulsed signal therapy and the treatment of osteoarthritis | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Accomplishments of the health technology assessment unit - 1995-2000 | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Extremity pumps for the treatment of primary peripheral edema | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Off-pump coronary artery bypass surgery | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Proceedings of the conference on Evidence Based Decision Making: How to Keep Score? | |
| 2001 | Canadian Task Force on Preventive Health Care (CTFPHC) | Screening strategies for colorectal cancer: systematic review and recommendations | |
| 2001 | Canadian Task Force on Preventive Health Care (CTFPHC) | Counseling for risky health habits: a conceptual framework for primary care practitioners | |
| 2001 | Canadian Task Force on Preventive Health Care (CTFPHC) | Prevention of early-onset group B streptococcal (GBS) infection in the newborn: systematic review and recommendations | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Vagus nerve stimulation (VNS) for treatment-resistant depression | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Transdermal contraceptive patch - a new birth control option | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Assessment of telemedicine applications - an update | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | The challenges of early assessment: leukotriene receptor antagonists | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | New fluoroquinolones in community-acquired pneumonia: a clinical and economic evaluation | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Do neuraminidase inhibitors prevent influenza? | |
| 2001 | British Columbia Office of Health Technology Assessment (BCOHTA) | Percutaneous radio-frequency neurotomy treatment of chronic cervical pain following whiplash injury: reviewing evidence and needs | |
| 2001 | British Columbia Office of Health Technology Assessment (BCOHTA) | Pulsed signal therapy for musculoskeletal conditions | |
| 2001 | Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) | Issues concerning prenatal screening and diagnosis of Down syndrome | |
| 2001 | Canadian Task Force on Preventive Health Care (CTFPHC) | Prevention and treatment of violence against women: systematic review & recommendations. | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Uncomplicated senile cataract surgeries in Alberta | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Intensive intervention programs for children with autism | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Decisions on the status of health technologies | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Horizon scanning for health technologies relevant to Alberta | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Overview of the regulation of acupuncture in Alberta | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Vagus nerve stimulation for refractory epilepsy | |
| 2001 | Medical Advisory Secretariat (MAS) | Intracoronary radiation therapy: an evidence-based analysis | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Keratoprosthesis for the treatment of severe bilateral cornea disease | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Profore compression bandage treatment of venous leg ulcers | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Anakinra: Interleukin-1 receptor antagonist therapy for rheumatoid arthritis | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Nursing skill mix and health care outcomes | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | The use of low level laser therapy in wound care in Alberta, Canada: results of a survey of physical therapists involved in rehabilitation, long term care and home care | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Omapatrilat for the management of heart failure and hypertension | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Inhaled insulin for the treatment of diabetes mellitus | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tacrolimus ointment for the treatment of atopic dermatitis | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Rosuvastatin: do we need another statin? | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Oxygen carriers ('blood substitutes') | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | A population-based cohort study of surveillance mammography after treatment of primary breast cancer | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Novel antipsychotics for patients with bipolar disorder: a systematic review | |
| 2001 | Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) | Assertive community treatment for people with persistent and particularly severe mental illness | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Behavioural interventions for preschool children with autism | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Non-penetrating glaucoma surgery using AquaFlow(TM) collagen implants | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | The Oxford unicompartmental knee replacement for osteoarthritis | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Vagus nerve stimulation for refractory epilepsy | |
| 2000 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Drug treatments for Alzheimer's disease. III. A review of pharmacoeconomic evaluations | |
| 2000 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Drug treatments for Alzheimer's disease. I. A comparative analysis of clinical trials | |
| 2000 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Drug treatments for Alzheimer's disease. II. A review of outcome measures in clinical trials | |
| 2000 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Entacapone: adjunctive use in patients with advanced Parkinson's disease | |
| 2000 | Alberta Heritage Foundation for Medical Research (AHFMR) | Laparoscopic adjustable gastric banding for clinically severe (morbid) obesity | |
| 2000 | Alberta Heritage Foundation for Medical Research (AHFMR) | Conductive education for children with cerebral palsy | |
| 2000 | Alberta Heritage Foundation for Medical Research (AHFMR) | Framework for regional health authorities to make optimal use of health technology assessment | |
| 2000 | Alberta Heritage Foundation for Medical Research (AHFMR) | Making managerial health care decisions in complex, high velocity environments | |
| 2000 | Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) | The excimer laser in ophthalmology: a state-of-knowledge update | |
| 2000 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | The treatment of venous leg ulcers and optimal use of Apligraf (TM) | |
| 2000 | Alberta Heritage Foundation for Medical Research (AHFMR) | NOW(R) S. pneumoniae test | |
| 2000 | Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) | Transcutaneous bilirubinometry in the context of early postnatal discharge | |
| 2000 | Alberta Heritage Foundation for Medical Research (AHFMR) | MRI in fetal diagnosis | |
| 2000 | Alberta Heritage Foundation for Medical Research (AHFMR) | Melacine vaccine | |
| 2000 | Alberta Heritage Foundation for Medical Research (AHFMR) | Etanercept (Enbrel(R)) | |
| 2000 | Alberta Heritage Foundation for Medical Research (AHFMR) | Vagus nerve stimulation |